Related Experiment Video
Updated: Feb 28, 2026

05:58
Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
Published on: October 13, 2023
1.7K
Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells
Joshua M Jackson1, Małgorzata A Witek, Joyce W Kamande
1Department of Chemistry, University of Kansas, USA. ssoper@ku.edu.
Chemical Society Reviews
|June 21, 2017
Summary
Microfluidic technologies and materials significantly impact circulating tumor cell (CTC) analysis for cancer patients. This review details how these factors influence CTC isolation and downstream genetic analysis for improved patient outcomes.
Area of Science:
- Biomedical Engineering
- Oncology
- Analytical Chemistry
Background:
- Circulating tumor cells (CTCs) offer minimally invasive insights into cancer prognosis, disease monitoring, and treatment resistance.
- Accurate CTC isolation is crucial for reliable downstream genetic and gene expression analyses.
- Microfluidic technologies are increasingly vital for efficient and sensitive CTC detection.
Purpose of the Study:
- To critically review microfluidic technologies for circulating tumor cell (CTC) isolation.
- To analyze the impact of material properties on CTC isolation efficiency and performance.
- To discuss how CTC isolation enables downstream molecular analyses for clinical decision-making.
Main Methods:
- Comprehensive literature review of microfluidic-based CTC isolation techniques.
- Analysis of various microfluidic architectures and isolation principles (e.g., physical properties, immunoaffinity).
- Evaluation of material effects (e.g., surface chemistry, biocompatibility) on CTC capture and viability.
Main Results:
- Microfluidic device design and material selection critically influence CTC isolation sensitivity and specificity.
- Different microfluidic approaches exhibit varying performance characteristics for CTC enrichment.
- Material choice affects CTC integrity and suitability for downstream genetic mutation and gene expression analysis.
Conclusions:
- Optimized microfluidic technologies and appropriate material selection are essential for advancing CTC-based cancer diagnostics and prognostics.
- Effective CTC isolation facilitates critical molecular profiling for personalized cancer therapy.
- Further research into novel materials and integrated microfluidic systems will enhance CTC analysis capabilities.

